drugset / Trial / NCT00303004

Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome

NCT00303004

Phase 3 Completed 20 enrolled Rigshospitalet, Denmark
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to investigate if combination treatment with Bosentan and Sildenafil to patients with Eisenmenger syndrome is beneficial.

Timeline

Start
2006-03
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bosentan Other / unclassified
Subject Sildenafil Unknown 50 mg

Indications